Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder
Open Access
- 12 April 2021
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 238 (8) , 2179-2189
Abstract
Rationale: Alcohol use disorder is a common and devastating mental illness for which satisfactory treatments are still lacking. Nalmefene, as an opioid receptor modulator, could pharmacologically support the reduction of drinking by reducing the (anticipated) rewarding effects of alcohol and expanding the range of treatment options. It has been hypothesized that nalmefene acts via an indirect modulation of the mesolimbic reward system. So far, only a few imaging findings on the neuronal response to nalmefene are available. Objectives: We tested the effect of a single dose of 18 mg nalmefene on neuronal cue-reactivity in the ventral and dorsal striatum and subjective craving. Methods: Eighteen non-treatment-seeking participants with alcohol use disorder (67% male, M = 50.3 ± 13.9 years) with a current high-risk drinking level (M = 76.9 ± 52 g of pure alcohol per day) were investigated using a cue-reactivity task during functional magnetic resonance imaging (fMRI) in a double-blind, placebo-controlled, cross-over study/design. In addition, self-reported craving was assessed before and after exposure to alcohol cues. Results: An a priori defined region of interest (ROI) analysis of fMRI data from 15 participants revealed that nalmefene reduced alcohol cue-reactivity in the ventral, but not the dorsal striatum. Additionally, the subjective craving was significantly reduced after the cue-reactivity task under nalmefene compared to placebo. Conclusion: In the present study, reduced craving and cue-reactivity to alcohol stimuli in the ventral striatum by nalmefene indicates a potential anti-craving effect of this drug via attenuation of neural alcohol cue-reactivity.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (402170461, 402170461, 324164820, 324164820, 421888313, 437718741)
This publication has 65 references indexed in Scilit:
- Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month StudiesAlcohol and Alcoholism, 2013
- Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed NalmefeneBiological Psychiatry, 2013
- Translating the neuroscience of alcoholism into clinical treatments: From blocking the buzz to curing the bluesNeuroscience & Biobehavioral Reviews, 2010
- Identifying the neural circuitry of alcohol craving and relapse vulnerabilityAddiction Biology, 2008
- Naltrexone for the Management of Alcohol DependenceNew England Journal of Medicine, 2008
- Effect of Naltrexone and Ondansetron on Alcohol Cue–Induced Activation of the Ventral Striatum in Alcohol-Dependent PeopleArchives of General Psychiatry, 2008
- Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholicsNeuroImage, 2007
- Alcohol-associated stimuli activate the ventral striatum in abstinent alcoholicsJournal of Neural Transmission, 2001
- A Neural Substrate of Prediction and RewardScience, 1997
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991